Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	47	46	90	91	-	-
Market Cap Growth	-45.86%	-48.30%	-1.34%	-	-	-
Enterprise Value	60	59	98	97	-	-
Last Close Price	30.86	30.50	59.00	59.80	-	-
PE Ratio	57.15	56.57	509.93	132.51	-	-
PS Ratio	0.63	0.62	1.46	1.48	-	-
PB Ratio	-	-	3.96	4.06	-	-
P/TBV Ratio	-	-	4.03	4.15	-	-
P/FCF Ratio	-	7.96	81.55	91.19	-	-
P/OCF Ratio	8.06	7.96	18.09	15.73	-	-
EV/Sales Ratio	0.80	0.80	1.60	1.59	-	-
EV/EBITDA Ratio	22.03	21.83	36.62	32.66	-	-
EV/EBIT Ratio	55.87	55.36	94.35	62.66	-	-
EV/FCF Ratio	-	10.16	89.31	97.71	-	-
Debt / Equity Ratio	-	-	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	-	-	1.78	2.04	1.45	1.49
Debt / FCF Ratio	-	-	7.86	10.73	-	-
Net Debt / Equity Ratio	-	-	0.34	0.44	0.26	-0.05
Net Debt / EBITDA Ratio	-	-	2.88	3.30	1.68	-0.36
Net Debt / FCF Ratio	-	-	7.03	9.87	-9.51	0.43
Asset Turnover	-	-	1.42	1.39	1.26	-
Inventory Turnover	-	-	2.23	1.98	1.84	-
Quick Ratio	-	-	0.27	0.14	0.19	0.89
Current Ratio	-	-	1.92	1.79	2.07	2.61
Return on Equity (ROE)	-	-	0.78%	2.99%	8.43%	-
Return on Assets (ROA)	-	-	1.51%	2.20%	3.88%	-
Return on Invested Capital (ROIC)	4.61%	5.40%	1.10%	3.17%	8.12%	8.99%
Return on Capital Employed (ROCE)	-	-	3.50%	5.00%	8.60%	8.20%
Earnings Yield	1.75%	1.77%	0.20%	0.76%	-	-
FCF Yield	-	12.56%	1.23%	1.10%	-	-
Dividend Yield	5.14%	-	-	2.65%	-	-
Payout Ratio	-	-	-	351.72%	93.81%	-
Buyback Yield / Dilution	0.16%	0.16%	-	-	-	-
Total Shareholder Return	5.26%	0.16%	-	2.65%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.